What does Massachusetts Senate Bill S 2520 do?

S 2520: An Act relative to pharmaceutical access, costs and transparency

When was Massachusetts Senate Bill S 2520 introduced?

S 2520 was introduced on Nov 15, 2023.

Yes, S 2520 has passed the Senate on Nov 15, 2023.

Yes, S 2520 has passed the House on Jul 24, 2024.

The latest action on S 2520 by the Senate was: Reported by S3012 on Dec 30, 2024.

S 2520 was introduced by: Senate Committee on Bills in the Third Reading.

Yes, there is one legislator voting record available for S 2520

Sponsors

Votes

NO: 0

OTHER: 0

Sources

Actions

Dec 30, 2024 | Senate
- Reported by S3012
Jul 25, 2024 | House
- House insisted on its amendment
- Committee of conference appointed - (Lawn-F. Moran-Barrows), in concurrence
Jul 25, 2024 | Senate
- Rules suspended
- Senate NON-concurred in the House amendment
- Committee on conference (Friedman-Cronin-Tarr), appointed
Jul 24, 2024 | House
- Committee reported that the matter be placed in the Orders of the Day for the next sitting with the amendment pending
- Read second
- Amendment (as recommended by the committee on House Ways and Means) adopted
- Ordered to the third reading
- Rules suspended
- Read third
- Amended by substitution of a new text (see H4910)
- Passed to be engrossed - 158 YEAS to 0 NAYS (See YEA and NAY No. 142 )
Jul 22, 2024 | House
- Committee recommended ought to pass with an amendment, substituting the text of an amendment, see H4891
- Referred to the committee on House Steering, Policy and Scheduling with the amendment pending
Nov 20, 2023 | House
- Read; and referred to the committee on House Ways and Means
Nov 15, 2023 | Senate
- Reported from the committee on Senate Bills in the Third Reading
- New draft of S2499
- Passed to be engrossed -see Roll Call #99 (Yeas 39 to Nays 0)

Bill Texts

Documents

Looks like we don't have any documents available at this moment.

Sources